All In MedTech

Device Trial Radar · NCT07941037

Effect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the Hand

Effect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the Hand: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 154 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

154

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Mar 2027

Study completion Oct 2027

Sponsor

Lead sponsor
MSK Doctors & Associates LtdNot on our public-company list
Sponsor type
Industry
First posted
Nov 17, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 39 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial will investigate whether non-compressive therapeutic gloves improve hand function and reduce pain in people with hand osteoarthritis. The gloves contain semiconductor elements embedded in their fabric. Researchers will compare these gloves with visually identical placebo gloves that do not contain semiconductor elements. The main question is whether the active gloves improve hand function after 12 weeks compared with placebo gloves. Researchers will also assess pain, grip strength, symptoms and changes seen on magnetic resonance imaging (MRI) over nine months. The study will involve at least 154 participants aged 39 years or older with diagnosed hand osteoarthritis who do not require immediate hand surgery. It will take place at MSK House in Sleaford, United Kingdom. After providing written informed consent, participants will be assigned by chance to one of two groups. Each participant will have an equal chance of receiving active or placebo gloves. Neither participants nor the clinical team will know which gloves have been assigned. Participants will: * Wear the assigned glove or gloves on their affected hand or hands for at least 20 hours each day, including overnight, during the first 12 weeks. * Continue wearing the gloves for at least 12 hours each day, including overnight, for the remainder of the nine-month study. * Complete questionnaires about hand pain and function before treatment and at three, six and nine months. * Attend the study site at the beginning and at nine months for assessments, including grip strength testing and MRI scans of the hand and wrist. * Record their hand pain, glove use and pain medication use in a weekly diary. Participants may also complete a short video-based movement assessment at the first and last study visits. The main measure of hand function will be the Australian Canadian Osteoarthritis Hand Index (AUSCAN), a questionnaire about hand symptoms and difficulty with everyday activities. Other assessments will measure pain, hand function, grip strength and changes in the hand joints. The research team will record unwanted effects during the study. Participants who experience discomfort, irritation or a skin reaction will be advised to remove the gloves and contact the study team. The findings will help determine whether these therapeutic gloves have a role in managing hand osteoarthritis.

Conditions

  • Hand Osteoarthritis

Interventions

  • Incrediwear Semiconductor-Embedded GlovesDevice

    Non-compressive therapeutic gloves with semiconductor elements incorporated into the fabric. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use.

  • Placebo GlovesOther

    Visually identical non-compressive gloves without semiconductor elements. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Hand Function Assessed Using the Australian Canadian Osteoarthritis Hand Index (AUSCAN)Time frame: Baseline and 12 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.